Has Lucian Lozonschi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $353,644 in general payments to Lucian Lozonschi, MD across 75 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lucian Lozonschi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lucian Lozonschi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lucian Lozonschi, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Tampa, FLNPI 1740388123

Payments from drug & device makers

What this record shows

This record is dominated by other: $343,050 of the $353,644 with a category attached, or 97.0%. Tendyne Holdings, Inc. accounts for 97.0% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $347,314, more than ten times the $355 reported in 2019. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$353,644in general payments, 2019–2025

Across 75 payments — averaging $4715.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Tendyne Holdings, Inc.$343K
Transmedics, Inc.$5K
Abbott$1K
Atricure, Inc.$965
Abiomed$858
Johnson & Johnson$516
plus $2K from 14 others

$220,733in research payments, 2019–2025

Across 44 payments — averaging $5016.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Transmedics, Inc.$157K
Abbott$42K
Medtronic$15K
Edwards Lifesciences$7K

What the payments were for

Travel & lodging$4,8261%
Food & beverage$5,7692%
Other$343,05097%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Tendyne Holdings, Inc.	1	$343,050
Transmedics, Inc.	5	$4,826
Abbott	13	$1,221
Atricure, Inc.	15	$965
Abiomed	11	$858
Johnson & Johnson(2 entities)	6	$516
Corcym Inc	3	$347
Edwards Lifesciences	2	$323
Baxter Healthcare	3	$221
Innovation Technologies Inc	1	$174
Paragonix Technologies, Inc.	3	$160
LSI Solutions Inc	1	$158
KCI USA, Inc.	2	$139
Medtronic	1	$127
Clearflow Inc.	1	$126
Livanova USA, Inc.	1	$121
La Jolla Pharmaceutical Company	1	$109
Smith+Nephew	2	$91
Maquet Cardiovascular L.L.C.	1	$62
Solventum Corporation	2	$51

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ORGAN CARE SYSTEM$4,826
THORATEC HEARTMATE 3 LVAS IMPLANT KIT$507
Perceval$341
SYNERGY ABLATION SYSTEM$304
DERMABOND PRINEO$240
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$210
Irrisept$174
HeartMate 3 Left Ventricular Assist Device$168
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$163
RAM$158
Impella$144
COREVALVE EVOLUT R$127
Pleuraflow System with FlowGlide$126
VISTASEAL$124
NA$124
MONOCRYL$116
Echelon Flex$116
HeartMate$114
GIAPREZA$109
CardioMEMS HF System$108

How this compares

$353,644 in reported general payments places this provider in the 95th percentile of 408 thoracic surgery (cardiothoracic vascular surgery) providers in Florida.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Florida →

Medicare billing

Part B allowed, 2024

$123,277

Medicare patients

148

Services billed

233

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Tampa

Jacques FontaineTampa$630K
Andrew ShermanTampa$517K
Narendra SastryTampa$50K
Eric TolozaTampa$48K
Anthony NunezOrlando$4.8M
Barry WintonLargo$687K
Paul DigiorgiPort Charlotte$666K
John PirrisJacksonville$640K
Rogerio CarrilloHialeah$515K
Daniel O'HairFort Myers$429K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →